How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
about
The viral and cellular microRNA targetome in lymphoblastoid cell linesEpstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developmentsPotential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr VirusEpstein-Barr Virus: Diseases Linked to Infection and TransformationNF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic ImplicationsMolecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.Developments in Burkitt's lymphoma: novel cooperations in oncogenic MYC signaling.Latent Epstein-Barr virus can inhibit apoptosis in B cells by blocking the induction of NOXA expressionBurkitt lymphoma: pathogenesis and immune evasion.Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumorsEBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBVEpstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphomaFar upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte SurvivalInfection, stem cells and cancer signals.γ-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis.Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma.Epigenetic reprogramming of host genes in viral and microbial pathogenesisInflammation: what role in pediatric cancer?Medulloblasoma: challenges for effective immunotherapy.An update on viral association of human cancers.Burkitt's Lymphoma in a Pregnant Woman: Case Report and Review of the Literature.EBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infectionHITS-CLIP and PAR-CLIP advance viral miRNA targetome analysis.The Epstein-Barr virus and the pathogenesis of lymphoma.Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomasEBV Persistence--Introducing the Virus.Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells.Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis.Current Trends and Alternative Scenarios in EBV Research.Malaria, Epstein-Barr virus infection and the pathogenesis of Burkitt's lymphoma.EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1: Type IIb latency.Molecular and clinicopathological analysis of Epstein-Barr virus-associated posttransplant smooth muscle tumors.Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells.Epstein-Barr virus-associated lymphomasAn EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model
P2860
Q21131404-17E05D7B-8204-4799-98AA-B6312D10AA36Q26775442-BB6AEC04-8F37-40C3-8CF7-E526EDDBCEDAQ26852071-1D8087F3-B313-4311-88A5-F1D6CD1E4E92Q28074586-30F5484C-A0F9-4DCF-BA55-B447911E8689Q28078299-1D3AD4D9-D7A3-458A-B74E-C23BE8A4134FQ30610963-5B98B035-7F0A-42D4-87F9-FC57C0D9462BQ34039568-5BF36C32-0FA9-4C3C-9FA9-7E47F49C91D7Q34103135-5A5222A7-3CCD-414D-9165-F49B287B5EABQ34189497-0ECDEED9-9AD9-465E-A1C7-A96F6A4F032EQ35071179-E8273BED-B964-475F-986B-9C8A1559B0AAQ35858022-921CDE50-3B09-44C1-B8DF-465A118E6B28Q36180229-D4F811CD-99DB-46F8-B596-C01661CCAF5BQ36204326-22534E1B-BAAE-4BA0-9FF2-6FE4EF0BE296Q36246412-21CBB071-FFE2-4BD7-8FBD-123676CBB8ACQ36433955-72D059E3-8DED-43B5-BDFD-B72569FC4FD9Q36727010-6CFD3D15-6BE9-447A-90DB-3134B6A2B6FFQ37427764-FD2FC0D0-620B-48B8-9ED8-34F412FD3E4AQ37512075-0CE9153E-3A03-45B5-85CA-4587CF1FC976Q37781197-41688D93-A4C7-4DD5-8849-81092213C1B1Q37967667-2C3F600B-74E5-4DDC-96B2-1921C9EE9C21Q37968929-B2D00D96-6CE8-45A1-A63E-03C92C8B0E47Q38082388-4A5B9185-392E-4396-9113-E0721131C0BBQ38114083-2B9BAC06-4F00-4D38-AEE6-A314181D08D0Q38156169-779FA160-AEBB-42EA-A7C5-B2F778E966A3Q38221158-D174C11F-DA24-4052-B63B-C4594F1E8109Q38258049-CCF7F1C3-FA58-4CCA-95D2-69311B0FFD89Q38296711-D7A7BE21-4571-4FBC-94F4-F6D6658DC5E0Q38596344-556D5802-9947-429F-97AC-8CEF1124E686Q38768957-482A445D-0895-4240-811B-B341571A0A50Q38968887-D88EBC94-0519-43E7-84AA-D0CE386E8CC4Q39016336-8BAC1B7C-1A1C-4D09-A90D-C667EC4456F5Q40123116-9C349096-7F12-4A85-9872-CF54112120C8Q43225878-1F6053A6-137B-4149-AA58-07FE76318173Q45358957-073FD25F-2CF2-481A-8504-6045FC8B3722Q52643503-AEC4FB65-D6FA-4C62-B2B1-F37751C30948Q56930876-83D461AF-E453-4E7E-957D-9023375F78DBQ57025486-ED429C73-297D-47B3-923B-86F1B230EB98
P2860
How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How does Epstein-Barr virus (E ...... genesis of Burkitt's lymphoma?
@en
How does Epstein-Barr virus
@nl
type
label
How does Epstein-Barr virus (E ...... genesis of Burkitt's lymphoma?
@en
How does Epstein-Barr virus
@nl
prefLabel
How does Epstein-Barr virus (E ...... genesis of Burkitt's lymphoma?
@en
How does Epstein-Barr virus
@nl
P2860
P921
P1476
How does Epstein-Barr virus (E ...... genesis of Burkitt's lymphoma?
@en
P2093
Martin J Allday
P2860
P304
P356
10.1016/J.SEMCANCER.2009.07.007
P5008
P577
2009-07-25T00:00:00Z
2009-12-01T00:00:00Z